谷冬
Lv3
380 积分
2022-07-20 加入
-
Cancer incidence and mortality in China, 2022
1个月前
已完结
-
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
2个月前
已完结
-
[Report of cancer epidemiology in China, 2015]
2个月前
已完结
-
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
2个月前
已完结
-
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
2个月前
已完结
-
[Guidelines for the early evaluation and management of chronic kidney disease in China]
2个月前
已完结
-
Current developments in gastric cancer: from molecular profiling to treatment strategy
3个月前
已完结
-
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
3个月前
已完结
-
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
3个月前
已完结
-
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
3个月前
已完结